AIM: Immunohistochemical analysis of protein expression is central to most clinical translational studies and defines patient treatment or selection criteria for novel drugs. Interobserver variation is rarely analysed despite recognition that this is a key area of potential inaccuracy. Therefore our aim was to examine observer variation and suggest the revision of current standards. <br></br> <br></br> METHODS AND RESULTS: We analysed inter- and intra-observer variation, by interclass correlation coefficient (ICCC) and kappa statistics, in 8661 samples. Intra-observer assessment of nuclear, cytoplasmic and membrane staining for seven proteins in 1323 samples resulted in an ICCC of 0.94 and a kappa-value of...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limi...
<div><p>Background</p><p>The biomarker discovery field is replete with molecular signatures that hav...
AIM: Immunohistochemical analysis of protein expression is central to most clinical translational s...
Background: Clinical translation of immunohistochemistry (IHC) biomarkers requires reliable and repr...
Immunohistochemical staining for mismatch repair proteins has during recent years been established a...
<p>Shown are for each pathologist the fraction of MIB-1-LI results over the mean value calculated fo...
Background: Scoring of immunohistochemistry (IHC) staining is often done by non-pathologists, especi...
The assessment of PD-L1 expression in TNBC is a prerequisite for selecting patients for immunotherap...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Quantification of protein expression based on immunohistochemistry (IHC) is an important step for tr...
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limi...
BACKGROUND: In breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ...
Kappa statistics have been widely used in the pathology literature to compare interobserver diagnost...
BackgroundIn breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ha...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limi...
<div><p>Background</p><p>The biomarker discovery field is replete with molecular signatures that hav...
AIM: Immunohistochemical analysis of protein expression is central to most clinical translational s...
Background: Clinical translation of immunohistochemistry (IHC) biomarkers requires reliable and repr...
Immunohistochemical staining for mismatch repair proteins has during recent years been established a...
<p>Shown are for each pathologist the fraction of MIB-1-LI results over the mean value calculated fo...
Background: Scoring of immunohistochemistry (IHC) staining is often done by non-pathologists, especi...
The assessment of PD-L1 expression in TNBC is a prerequisite for selecting patients for immunotherap...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Quantification of protein expression based on immunohistochemistry (IHC) is an important step for tr...
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limi...
BACKGROUND: In breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ...
Kappa statistics have been widely used in the pathology literature to compare interobserver diagnost...
BackgroundIn breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ha...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limi...
<div><p>Background</p><p>The biomarker discovery field is replete with molecular signatures that hav...